Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CBL |
Variant | del exon9 |
Impact List | deletion |
Protein Effect | loss of function |
Gene Variant Descriptions | CBL del exon9 is a CBL splice variant caused by a mutation resulting in the deletion of exon 9 (PMID: 19276253). Del exon9 demonstrates increased ubiquitination and reduced protein stability of Cbl, and failure to suppress Erk phosphorylation in cell culture (PMID: 26152360). |
Associated Drug Resistance | |
Category Variants Paths |
CBL mutant CBL exon9 CBL del exon9 CBL mutant CBL inact mut CBL del exon9 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04493138 | Phase Ib/II | Azacitidine + Quizartinib | Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations | Recruiting | USA | 0 |